Candriam S.C.A. - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 56 filers reported holding NEUROCRINE BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q1 2020$601,000
-2.3%
4000.0%0.01%0.0%
Q4 2019$615,000
+11.6%
4000.0%0.01%0.0%
Q3 2019$551,000
+4.6%
4000.0%0.01%0.0%
Q2 2019$527,000
+93.0%
400
+100.0%
0.01%
+133.3%
Q1 2019$273,000
+15.7%
2000.0%0.00%
-25.0%
Q4 2018$236,0002000.00%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q2 2020
NameSharesValueWeighting ↓
CSS LLC/IL 15,659,000$23,207,6871.52%
SONA ASSET MANAGEMENT (US) LLC 17,500,000$26,317,9521.09%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,765,000$40,113,0990.86%
Warberg Asset Management LLC 1,271,000$1,885,8460.38%
SSI INVESTMENT MANAGEMENT LLC 2,296,000$3,406,1160.28%
Paloma Partners Management Co 3,125,000$4,694,5900.16%
FRANKLIN RESOURCES INC 54,750,000$81,769,1250.04%
Rock Springs Capital Management LP 1,000,000$1,497,9500.04%
LORD, ABBETT & CO. LLC 4,666,000$6,9220.03%
D. E. Shaw & Co., Inc. 14,351,000$21,373,1970.02%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders